Park Ki Hyun, Shin Jung-Ho, Hwang Jin Ho, Kim Su Hyun
Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea.
Korean J Crit Care Med. 2017 Aug;32(3):256-264. doi: 10.4266/kjccm.2017.00136. Epub 2017 Aug 31.
Fluid overload prior to continuous renal replacement therapy (CRRT) is an important prognostic factor. Thus, precise evaluation of fluid status is necessary to treat such patients. In this study, we investigated whether fluid assessment using bioelectrical impedance analysis (BIA) can predict outcomes in critically ill patients requiring CRRT.
A prospective observational study was performed in patients who were admitted to the intensive care unit and who required CRRT. BIA was conducted before CRRT; then, the ratio of extracellular water to total body water (ECW/TBW) was derived to estimate volume status.
A total of 31 patients treated with CRRT were included. There were 18 men (58.1%), and the median age was 67 years (interquartile range, 51 to 78 years). Fourteen patients (45.2%) died within 28 days after CRRT initiation. Patients were divided into 16 with ECW/TBW ≥0.41 and 15 with ECW/TBW <0.41. Survival rate within 28 days was different between the two groups (P = 0.044). Cox regression analysis revealed a relationship between ECW/TBW ≥0.41 and 28-day mortality, but it was not statistically significant (hazard ratio, 3.0; 95% confidence interval, 0.9 to 9.8; P = 0.061). Lastly, the area under the curve of ECW/TBW for 28-day mortality was analyzed. The area under the curve of ECW/TBW was 0.73 (95% confidence interval, 0.54 to 0.92), and this was significant (P = 0.037).
Fluid status can be assessed using BIA in critically ill patients requiring CRRT, and BIA can predict mortality. Further large trials are needed to confirm the usefulness of BIA in critically ill patients.
连续性肾脏替代治疗(CRRT)前的液体超负荷是一个重要的预后因素。因此,精确评估液体状态对于治疗此类患者是必要的。在本研究中,我们调查了使用生物电阻抗分析(BIA)进行液体评估是否能预测需要CRRT的危重症患者的预后。
对入住重症监护病房且需要CRRT的患者进行了一项前瞻性观察性研究。在CRRT前进行BIA;然后,得出细胞外液与总体液的比率(ECW/TBW)以评估容量状态。
共纳入31例接受CRRT治疗的患者。其中男性18例(58.1%),中位年龄为67岁(四分位间距,51至78岁)。14例患者(45.2%)在CRRT开始后28天内死亡。患者被分为ECW/TBW≥0.41的16例和ECW/TBW<0.41的15例。两组28天内的生存率不同(P = 0.044)。Cox回归分析显示ECW/TBW≥0.41与28天死亡率之间存在关联,但无统计学意义(风险比,3.0;95%置信区间,0.9至9.8;P = 0.061)。最后,分析了ECW/TBW对28天死亡率的曲线下面积。ECW/TBW的曲线下面积为0.73(95%置信区间,0.54至0.92),具有显著性(P = 0.037)。
在需要CRRT的危重症患者中,可以使用BIA评估液体状态,且BIA可预测死亡率。需要进一步的大型试验来证实BIA在危重症患者中的实用性。